| | Roundtable: Creating Sustainable Change in HCP Engagement Tuesday, December 8 | 11am ET / 8am PT To succeed in today’s environment, biopharmaceutical companies must leverage analytics and adopt innovative approaches to engage HCPs and improve outcomes for their customers and communities. Join us for a roundtable discussion with leading industry innovators to discuss how biopharma manufacturers can successfully increase and improve HCP engagement. Register now. |
Pfizer passes COVID-19 vaccine safety milestone, reveals 95% efficacy ahead of EUA Despite impressive data, FDA's coronavirus vaccine reviews will take weeks, not days, official says Azar expects 40M COVID-19 vaccine doses ready to distribute by end of December AMA calls for increased COVID-19 prevention in correctional facilities, end to disinformation campaigns Airlines rally cold-chain supplies to ship Pfizer, Moderna's frigid COVID-19 shots FDA greenlights first all-in-one home COVID-19 test, with results in 30 minutes China's Sinovac sees speedy immune response with COVID-19 shot in early trials AstraZeneca taps CCT Research for COVID-19 vaccine tests Biopharma roundup: Lucira's all-in-one home COVID-19 test wins OK; AstraZeneca taps CCT Research for trial recruitment Healthcare roundup: BCBSA estimates 9M vaccine doses could be missed this year Providence posts $214M loss during first 9 months of 2020 due to COVID-19 impact Featured Story | By Nick Paul Taylor Pfizer is preparing to file its COVID-19 vaccine for emergency use authorization (EUA) after passing a key safety milestone. CEO Albert Bourla, Ph.D., said Pfizer now has the median two-month follow-up data needed to secure EUA from the FDA, putting it a step closer to bringing its vaccine to market in the U.S. read more |
| |
|---|
|
Top Stories By Eric Sagonowsky As leading COVID-19 vaccines post positive phase 3 data and near FDA submissions, the agency official in charge of reviewing vaccines is emphasizing transparency and patience during the high-stakes process. Americans should expect reviews to take weeks rather than days, according to Peter Marks, head of the FDA’s Center for Biologics Evaluation and Research. read more By Robert King HHS Secretary Alex Azar expects 40 million doses of a COVID-19 vaccine will be ready by the end of the year as Pfizer and Moderna candidates near FDA approval. read more By Tina Reed The AMA's House of Delegates held a special meeting this week and voted to support of a handful of new policies, including supporting the compassionate release of some incarcerated individuals amid the pandemic and a measure to prevent bullying in healthcare. Here's what else they voted to support. read more By Fraiser Kansteiner With positive news on mRNA shots from Pfizer and Moderna tempered by concerns over cold-chain hurdles, airlines are rapidly working to ensure they have the frigid containers and shipping know-how in place to carry out the global rollout of a COVID-19 vaccine, Reuters reports. Meanwhile, container makers are doubling down on efforts to boost supplies, too. read more By Conor Hale The FDA has authorized its first all-in-one COVID-19 diagnostic that allows people to test themselves within their own home, from a swab to a result in about 30 minutes. read more By Ben Adams A week after one of its tests in Brazil was stopped amid a safety scare, Chinese biotech Sinovac has published data showing its experimental COVID-19 vaccine can quickly boost an immune response. read more By Ben Adams U.K. Big Pharma AstraZeneca and academic partner the University of Oxford are tapping research services firm CCT Research for their COVID-19 shot tests in Arizona. read more By Eric Sagonowsky,Angus Liu,Kyle Blankenship,Conor Hale,Fraiser Kansteiner The FDA approved an all-in-one home COVID-19 test developed by Lucira Health. AstraZeneca tapped CCT Research to help recruit trial participants in Arizona. J&J is pledging $100 million to fight health inequities over the next five years. And Americans are feeling slightly more confident about a vaccine, a recent poll found. read more By Healthcare Staff Follow along with the latest COVID-19 news straight from the Fierce Healthcare team. read more By Robert King Providence hospital system posted a $214 million loss for the first nine months of 2020 as the system struggles to recoup major losses caused by COVID-19. read more |
